EU listar 200 ”kritiska” läkemedel

En lista med 200 läkemedel som det är särskilt viktigt att förhindra brist på har tagits fram inom EU.

Clinigen Clinical Supplies Management GmbH

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

Ultimovacs studie uppnådde inte målen – ”Vi är besvikna”

Norska Ultimovacs cancervaccin uppnådde inte målen i en fas II-studie hos patienter med huvud- och halscancer. Cancervaccinet i kombination med en kontrollpunkt...

EMA review confirms a risk of new cancer after CAR-T

CAR-T cancer therapies can, in rare cases, induce secondary cancers. The European Medicines Agency (EMA) now recognises this and requires a warning label to be ...

Norway finds its path in life science

The life science sector in Norway is on the rise.

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

Higher throughput in less time

Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

Dansk-svenskt samarbete kring antibiotikaresistens i EU

Ett europeiskt referenslaboratorium för antibiotikaresistens ska etableras genom ett samarbete mellan Danmark och Sverige. Laboratoriet ska bidra med kunskap kr...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approval for new medicines. Marie Grådmark writes in a column that she is looking forward...

Västsvenska life science-aktörer rattar EU-projekt inom precisionsmedicin

Ett nytt projekt ska koppla samman innovationssystem i hela Europa för att få fart på implementeringen av precisionsmedicin. Och spindel i nätet är en rad tunga...

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Behandling av prostatacancer får positivt EU-utlåtande

Prostataläkemedlet Xtandi har nu fått ett positivt utlåtande i EU av den europeiska läkemedelsmyndigheten EMA:s rådgivande grupp CHMP.

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all citizens in Europe, writes Marie Gårdmark...

Aqilions licensdeal gav eko – ”Det var ett litet svenskt biotech som gjorde det”

Var extremt noga med dina vetenskapliga data, men lägg minst lika mycket tid och kraft på affärsutveckling. Det rådet ger Aqilions vd Sarah Fredriksson till bio...

Ny vd för Voc Diagnostics

Voc Diagnostics internrekryterar. Lotta Tollstoy Tegler som idag är ansvarig för kvalitets- och regulatoriska frågor är bolagets nya vd.

Kris för hajpat genredigeringsbolag – ”Stämningen har skiftat”

Upp som en sol, ner som en pannkaka. Så kan utvecklingen för det upphaussade amerikanska genredigeringsbolaget Tome Biosciences beskrivas.

Positiva besked för Cereno i både EU och USA – ”Stor glädje”

Cereno Scientific beviljas status som särläkemedel i EU för sin behandling av lungsjukdomen pulmonell arteriell hypertension, PAH. Samtidigt meddelas nya framsteg i USA.